Again, three recipients from each group were sacrificed on day 25, which revealed that the BCR/ABL1-Rora group recipients had a smaller gross splenic appearance with a significantly lower weight (Figure 7D and E) and significantly lower percentage and total number of leukemia cells (Figure 6F and G). This evidence concerns the gene BCR and leukemia.